METHYLPREDNISOLONE

Course overview

METHYLPREDNISOLONE IS AN FDA-APPROVED MEDICATION FOR THE MANAGEMENT AND TREATMENT OF ALLERGIC CONDITIONS, ARTHRITIS, ASTHMA EXACERBATIONS, LONG-TERM ASTHMA MAINTENANCE, ACUTE EXACERBATION OF MULTIPLE SCLEROSIS, AND AS AN ANTI-INFLAMMATORY AND IMMUNOSUPPRESSIVE AGENT. IT IS IN THE SYSTEMIC CORTICOSTEROID CLASS OF MEDICATIONS. THIS ACTIVITY OUTLINES THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR METHYLPREDNISOLONE AS A VALUABLE AGENT IN TREATING MANY ENDOCRINE, INFLAMMATORY, IMMUNOLOGIC, HEMATOLOGIC, AND RESPIRATORY DISORDERS.